Moderator | k | B | SE | p | |
---|---|---|---|---|---|
All vaccines recipients, 1st dose | Age | 60 | -0.004 | 0.002 | .082 |
%females | 76 | 0.048 | 0.034 | .162 | |
Placebo recipients, 1st dose | Age | 19 | -0.001 | 0.004 | .896 |
%females | 20 | -0.013 | 0.382 | .973 | |
All vaccines recipients, 2nd dose | Age | 17 | 0.001 | 0.003 | .965 |
%females | 25 | 0.134 | 0.189 | .485 | |
BNT162b2, 1st dose | Age | 26 | -0.005 | 0.002 | .041 |
%females | 33 | 0.115 | 0.188 | .545 | |
BNT162b2, 2nd dose | Age | 10 | -0.006 | 0.004 | .213 |
%females | 15 | 0.160 | 0.320 | .625 | |
PiCoVacc, 1st dose | %females | 6 | 0.242 | 0.272 | .424 |
ChAdOx1, 1st dose | Age | 8 | -0.012 | 0.009 | .231 |
%females | 12 | 0.688 | 0.435 | .145 |